Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
1 other identifier
observational
48
1 country
1
Brief Summary
Moyamoya disease is characterized by progressive stenosis of the genesis of the distal internal carotid arteries bilaterally and progressive generation of compensatory pathological vascular networks at the basis cranii, and these pathological vasculature has poor vascular reactivity. Perioperative circulatory management of patients with smoky vessels to ensure perfusion of brain tissue and integrity of brain network during surgery to minimize postoperative impairment of neurological functions, including motor, sensory, emotional and cognitive functions, is the key point of perioperative circulatory management of moyamoya disease. Functional Magnetic Resonance Imaging (fMRI) has been routinely used in various cerebrovascular diseases to further evaluate cerebrovascular reserve and cerebral network connectivity. The purpose of this study is to observe the changes in cerebral blood flow, cerebral oxygen metabolism, cerebral oxygen metabolism rate, and cerebral network connectivity in adult patients with moyamoya disease in cerebral ischemia-sensitive areas under anesthesia to provide a basis for exploring anesthesia management to improve cognitive function and cerebral network connectivity in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 18, 2023
CompletedStudy Start
First participant enrolled
October 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 13, 2025
February 1, 2025
2.2 years
September 11, 2023
February 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of brain functional network
Before sedation, after sedation and after maintenan the blood pressure at baseline 100%-120% for 15min
Secondary Outcomes (2)
Postoperative delirium
Day1-5 after surgery
Electroencephalogram changes
Before sedation, after sedation and after maintenan the blood pressure at baseline 100%-120% for 15min
Eligibility Criteria
We plan to recruit consecutive patients with moyamoya disease who are to undergo direct or indirect revascularization surgery from August 2023 to December 2025 at Beijing Tiantan Hospital of Capital Medical University.
You may qualify if:
- Patients with moyamoya disease scheduled for direct or indirect intracranial and extracranial revascularization surgery
- Age between 18-65 years
- Obtain written informed consent.
You may not qualify if:
- Patients with preoperative claustrophobia, sensory or motor aphasia that are unable to understand and cooperate with the examination
- Preoperative cranial imaging suggesting cerebral infarction lesion diameter \>15mm
- Patients allergic to anesthetic drugs
- Metal implants in the body
- Undergoing other experimental drug or instrumentation trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shu Li
Beijing Tiantan Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 18, 2023
Study Start
October 24, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
February 13, 2025
Record last verified: 2025-02